Optonol

Acquired

Miniature glaucoma implants for surgical precision

Neve Ilan, Israel · Founded 1996

Headquarters
Neve Ilan
Employees
11–50
Founded
1996
Business Model
B2B
Last Round
Series CFeb 2009
Rounds
1
Acquired by
Alcon Inc.Dec 2009

About

Optonol Ltd. was founded in 1996 as a spin-off of Jerusalem-based stent developer Medinol Ltd. The company developed the Ex-PRESS miniature glaucoma implant — a device smaller than a grain of rice made from surgical stainless steel with an internal diameter of 50 or 200 microns. The Ex-PRESS shunt is used in filtering surgery to lower intraocular pressure in glaucoma patients, offering a less invasive alternative to traditional trabeculectomy. Optonol's development center was located in Neve Ilan near Jerusalem, Israel. The company raised over $20 million from investors including Israel Healthcare Ventures and Pitango Venture Capital before being acquired by Alcon in 2010 for an initial payment of $150 million with additional milestone payments.

Summary

Optonol is a Healthcare company based in Neve Ilan, Israel, founded in 1996. Its most recent funding was a Series C round in Feb 2009. Investors include Pitango Growth.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionDec 2009

Sign up to see all 2 rounds

Series C through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Optonol on Indexed.vc
<a href="https://indexed.vc/companies/optonol"><img src="https://indexed.vc/api/badge/company/optonol" alt="Optonol on Indexed.vc" width="260" height="76" /></a>